ArticleRheumatology (Oxford, England)2026
Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren's disease and non-Sjogren's sicca.
Article in Rheumatology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of socioeconomic deprivation on risk and disease activity of Sjögren's disease.RMD open · 2026Article
Corrections and comments
- Commented on by
Authors and funding
15 authors.
Funding
Abstract
objectivesThe strong female sex bias in Sjögren's disease (SjD) remains poorly understood. We evaluated hormonal risk factors and steroidal hormones in a well-characterized cohort.
methodsNewly presenting patients investigated for SjD at a multidisciplinary clinic completed a hormonal risk factor questionnaire. One hundred eighty-four females with a diagnosis of SjD or non-SjD Sicca were included. Steroids were extracted from 88 consecutively recruited SjD and 59 Sicca serum samples and analysed via liquid chromatography tandem mass spectrometry. Sex steroid, glucocorticoid and mineralocorticoid data were compared with those from 165 healthy controls.
resultsA history of hirsutism was negatively associated with SjD even when corrected for smoking status, ethnicity, age and symptom duration (OR 0.14, 95% CI 0.04, 0.57; P = 0.006), whereas hysterectomy and ovary removal were positively associated, whether up to time of recruitment (hysterectomy OR 3.29, 95% CI 1.19, 9.11; P = 0.02) or to symptom onset (hysterectomy OR 5.8, 95% 1.52, 22.1; P = 0.01). Participants reporting hirsutism had higher androstenedione levels (2.51 vs 1.80 nmol/l; P = 0.03) and in pre-menopause, androstenedione and testosterone were higher in non-SjD sicca than both SjD and healthy controls. Within the whole cohort, androstenedione levels were inversely correlated with minor salivary gland focus score (r = -0.44; P = 0.03). Lower glucocorticoids were seen in both SjD and Sicca compared with healthy controls and negatively correlated with symptoms.
conclusionParticipants with SjD were less likely to report hirsutism and had lower androstenedione and testosterone pre-menopause when compared with non-SjD sicca. The role of androgens in modulating salivary gland inflammation should be further investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.